Novartis (NVSN) Stock Statistics & Valuation Metrics
Total Valuation
Novartis has a market cap or net worth of MXN 5.58T. The enterprise value is MXN 311.27B.
- Market Cap
- MXN 5.58T
- Enterprise Value
- MXN 311.27B
Share Statistics
Novartis has 2,034,819,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,034,819,500
- Owned by Insiders
- ―
- Owned by Institutions
- 1.69%
Financial Efficiency
Novartis’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 15.50%.
- Return on Equity (ROE)
- 0.30
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 15.50%
- Return on Capital Employed (ROCE)
- 0.19
- Revenue Per Employee
- 728.22K
- Profits Per Employee
- 186.74K
- Employee Count
- 75,267
- Asset Turnover
- 0.47
- Inventory Turnover
- 2.18
Valuation Ratios
The current PE Ratio of Novartis is 31.19. Novartis’s PEG ratio is -1.07.
- PE Ratio
- 31.19
- PS Ratio
- 5.57
- PB Ratio
- 8.22
- Price to FCF
- 19.97
- Price to Operating Cash Flow
- 18.08
- PEG Ratio
- -1.07
Income Statement
In the last 12 months, Novartis had revenue of 54.81B and earned 14.06B in profits. Earnings per share was 7.25.
- Revenue
- 54.81B
- Gross Profit
- 41.12B
- Operating Income
- 17.07B
- Pretax Income
- 16.44B
- Net Income
- 14.06B
- EBITDA
- 22.99B
- Earnings Per Share (EPS)
- 7.25
Cash Flow
In the last 12 months, operating cash flow was 17.32B and capital expenditures -2.48B, giving a free cash flow of 14.84B billion.
- Operating Cash Flow
- 17.32B
- Free Cash Flow
- 14.84B
- Free Cash Flow per Share
- 8.09
Dividends & Yields
Novartis pays an annual dividend of ―, resulting in a dividend yield of 2.97%
- Dividend Per Share
- ―
- Dividend Yield
- 2.97%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.01%
- Earnings Yield
- 3.23%
Stock Price Statistics
- Beta
- 0.30
- 52-Week Price Change
- 23.87%
- 50-Day Moving Average
- 2616.11
- 200-Day Moving Average
- 2658.66
- Relative Strength Index (RSI)
- 70.94
- Average Volume (3m)
- 80
Important Dates
Novartis upcoming earnings date is Feb 03, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Novartis as a current ratio of 1.12, with Debt / Equity ratio of 80.28%
- Current Ratio
- 1.12
- Quick Ratio
- 0.89
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- 1.11
- Interest Coverage Ratio
- 14.38
Taxes
In the past 12 months, Novartis has paid 2.40B in taxes.
- Income Tax
- 2.40B
- Effective Tax Rate
- 0.15
Enterprise Valuation
Novartis EV to EBITDA ratio is 15.39, with an EV/FCF ratio of 22.55.
- EV to Sales
- 6.29
- EV to EBITDA
- 15.39
- EV to Free Cash Flow
- 22.55
- EV to Operating Cash Flow
- 20.34
Balance Sheet
Novartis has MXN 8.97B in cash and marketable securities with MXN 48.31B in debt, giving a net cash position of -MXN 39.34B billion.
- Cash & Marketable Securities
- MXN 8.97B
- Total Debt
- MXN 48.31B
- Net Cash
- -MXN 39.34B
- Net Cash Per Share
- -MXN 19.33
- Tangible Book Value Per Share
- -MXN 15.53
Margins
Gross margin is 74.30%, with operating margin of 30.47%, and net profit margin of 18.06%.
- Gross Margin
- 74.30%
- Operating Margin
- 30.47%
- Pretax Margin
- 22.77%
- Net Profit Margin
- 18.06%
- EBITDA Margin
- 40.89%
- EBIT Margin
- 31.26%
Analyst Forecast
The average price target for Novartis is MXN 2,979.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- MXN 2,979.80
- Price Target Upside
- 2.36% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- -8.64%
- EPS Growth Forecast
- -35.71%
Scores
- Smart Score
- 7
- AI Score
- ―